Bluejay Diagnostics (BJDX) Net Equity Issued and Repurchased (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Net Equity Issued and Repurchased of $125000.0 for Q1 2026, down 97.22% sequentially from $4.5 million in Q4 2025.
Bluejay Diagnostics (BJDX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 4 years of Net Equity Issued and Repurchased data on file, last reported at $125000.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $125000.0; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (changed N/A YoY), and the FY2025 full-year result was $8.3 million, down 30.84% from the prior year.
- Net Equity Issued and Repurchased declined to $125000.0 in Q1 2026, from $4.5 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.6 million in Q2 2024 to a low of $125000.0 in Q1 2026.
- A 3-year average of $4.2 million and a median of $4.0 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125,000.00 |
| Mar 31, 2026 | 125,000.00 |
| Dec 31, 2025 | 4.50 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Jun 30, 2024 | 8.57 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2020 | -383.00 |
| Dec 31, 2020 | -383.00 |